Sagility Q1 FY27 Revenue Up 27.6% YoY to ₹1963.5 Crore; PAT Grows 35.1%
Sagility Limited reported Q1 FY27 consolidated results with revenue at ₹1,963.5 crore (US$ 207.8 million), up 27.6% YoY. Adjusted EBITDA grew 27.9% YoY to ₹471.6 crore, and Adjusted PAT increased 35.1% YoY to ₹269.7 crore. The company added 27 new clients and acquired CareSeed, expanding its healthcare quality services.
The substantial revenue and profit growth, combined with a strategic acquisition and expansion of client base, are significant positive developments that are likely to have a material impact on investor sentiment and the company's market position.
The company reported strong year-on-year growth in revenue, EBITDA, and PAT, along with significant new client additions and a strategic acquisition, indicating positive business performance and expansion.
Sagility Limited announced its consolidated financial results for the first quarter of FY27, ended June 30, 2026. The company reported a strong Q1 performance with revenue growth of 27.6% year-on-year (YoY), reaching INR 19,635 million (₹1,963.5 crore or US$ 207.8 million). This growth was primarily driven by a 27.3% organic YoY increase.
Adjusted EBITDA stood at INR 4,716 million (₹471.6 crore or US$ 49.9 million), a 27.9% YoY increase, representing 24.0% of revenue. Adjusted Profit After Tax (PAT) grew by 35.1% YoY to INR 2,697 million (₹269.7 crore or US$ 28.6 million), at 13.7% of revenue. Basic Earnings per share (EPS) increased by 45.9% YoY to INR 0.46, while Adjusted Basic EPS rose by 35.1% YoY to INR 0.58.
In terms of business highlights, Sagility secured $35.3 million of steady-state Annual Contract Value (ACV). The company added 27 new clients in Q1 FY27, expanding its total client base to 109. This includes the acquisition of CareSeed, which strengthens Sagility's position in healthcare quality, particularly for Medicare Advantage plans, by adding differentiated analytics and HEDIS capabilities. The acquisition contributed 26 new clients. The company ended the quarter with 47,307 employees across 29 delivery centers in 5 countries.
Commenting on the results, Ramesh Gopalan, Managing Director and Group CEO, highlighted the increasing demand for outcome-oriented managed services and the strategic importance of the CareSeed acquisition in enhancing healthcare quality capabilities. Srinivas Mattapalli, Group Chief Financial Officer, expressed confidence in the company's performance, supported by healthy business momentum, resilient profitability, and robust cash generation.
What to do with a filing like this
SAGILITY LIMITED filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by SAGILITY LIMITED. Read the original for the full detail.